Voyager Therapeutics Inc
Voyager Therapeutics Inc (VYGR) Historical Volatility
VYGR 30-day historical volatility is 44%. This ranks in the 12th percentile of readings over the past year.
Read more
Tracking VYGR historical volatility helps you see how much Voyager Therapeutics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Voyager Therapeutics Inc's HV tells you what really happened. Use our scanner to monitor VYGR 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The VYGR 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Voyager Therapeutics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, as well as for spinal muscular atrophy.
The company has collaboration and license agreements with Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. for the research, development, and commercialization of adeno-associated virus gene therapy products. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Voyager Therapeutics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where VYGR HV is running hot, cold, or in line. Make the VYGR 30 day historical volatility — and every other window — work for your edge instead of against it.
As of September 23, 2026
As of September 23, 2026
See how volatility has moved over time
Track VYGR historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.
Start your 14-day free trial→